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To assess the prevalence of genetic variation in
warfarin metabolism and its effects on
maintenance dose in patients requiring oral
anticoagulation
Pankaj Batra, Rajiv Agarwal
Batra Hospital and Medical Research Centre, New Delhi, India
Background: The study was conducted to assess the prevalence of
genetic variation in warfarin metabolism and its effect on main-
tenance dose in patients requiring oral anti-coagulation.
Methods: Among the patients finally selected for the study,
further evaluation done as per the following protocol: Genetic
testing for warfarin metabolism was done by collecting 3ml of
blood in EDTA vials for CYP2C9 polymorphisms. Simultaneously
patients were started on warfarin (7.5 mg) and then its dose
adjusted with frequent INR initially till it achieves therapeutic
levels. According to genetic composition patients will be catego-
rized into three groups’ namely extensive metaboliser, interme-
diate metaboliser& low metaboliser. Analysis of time required to
achieve target INR and stable maintenance dose done among the
above mentioned groups and analysis of bleeding or thrombo-
embolic episodes, if any, done among the above mentioned
groups.
Results: In this study 70% patients were normal metabolizers for
warfarin, 16.7% patients were intermediate metabolizers and only
13.3% patients were poor metabolizers. In this study it was seen
that mean maintenance dose of warfarin to achieve therapeutic
INR in patients with normal metabolism was 6 mg and mean time
required to achieve therapeutic INR in patients with normal
metabolism was 5.19 days, whereas mean maintenance dose to
achieve therapeutic INR in patients with intermediatemetabolism
was 4.7 mg and mean time required to achieve therapeutic INR in
patients with intermediate metabolism was 8.8 days. It was seen
that in patients with poor metabolismmeanmaintenance dose to
achieve therapeutic INR was 2.75mg and the mean time required
to achieve therapeutic INR was 15.5 days.
Conclusion: This study shows that patient with genetic mutation
in CYP2C9 required low maintenance dose of warfarin and
increased time to achieve therapeutic INR depending on the de-
gree of mutation.
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Introduction: Though the Wilkins’ score is the most commonly
used scoring system for predicting success of balloon mitral val-
votomy, it has important practical shortcomings such as inability
to include unicommissural v/s bicommissural involvement , in-
fluence of rhythm, involvement of underlying myocardium due to
fibrosis, no account of underlying PAH, degree of interatrial septal
bulge etc.This study was conducted to compare the influence of
individual parameters that comprise Wilkins’ score to know
whether one or more parameters of the score were more predic-
tive for PTMC outcomes than the composite score put together.
Methods: 100 patients of rheumatic mitral valve stenosis in sinus
rhythm who underwent balloon mitral valvotomy were studied
for outcomes of the procedure.The composite Wilkins’ score was
calculated for each patient as per protocol pre-PTMC, and the
outcomes of the procedure were studied comparing the total
Wilkins’ score and the individual parameters that comprised the
Wilkins’ score( M/S/T/C).Patients in AF were excluded because AF
itself is a well-documented negative predictor of successful PTMC
outcomes. Successful PTMC was defined as gain in MVA to more
than twice the pre PTMC area, or absolute more than 1.5 sq cm,
with no more than one grade increase in MR and no complica-
tions. Post PTMC MR was classified as either Commissural or
Leaflet tear and quantified as per standard ASE criteria, and post-
PTMC pericardial tamponade was also recorded.
Results: Over a 15-month data among the serially recruited 100
patients (M¼47:F¼53),the average Wilkins’ score was 9.72+/-
1.3.The average post ePTMC MVA was 1.7±0.5 cmsq.24 patients
Table- Baseline, 1 & 3-month parameters.
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Baseline 1 Month 3 Month p-value
Baseline vs.
3 month
Baseline 1 Month 3 Month p-value
Baseline vs.
3 month
Resting HR
(Bpm)
92.5 ±11.5 67.1± 6.2 65.5 ±6.2 <0.001 91.9 ±8.3 69.4 ±6.5 67.1 ±4.2 <0.001
Max. HR
(Bpm)
162.3± 10.1 128.7 ±8.5 127.4± 8.5 <0.001 163.1 ±10.3 132.8 ±8.2 129.3 ±7.7 <0.001
METS 6.4 ±1.7 8 ±1.1 8.3± 0.9 <0.001 6.3± 1.6 7.6 ±1 7.7± 1 <0.001
TED (min) 5.3± 1.7 6.6 ±1.2 6.8± 1.1 <0.001 5.1 ±1.8 5.8± 1.4 6 ±1.4 <0.001
TOS (min) 4.4± 1.6 5.5± 1.1 5.7 ±1 <0.001 4.3 ±1.7 4.6 ±1.3 4.8± 1.2 <0.001
MDG
(mm of Hg)
11.9± 6 8.1± 3.4 7.3± 3 <0.001 12.1± 6.2 9± 4.2 8.4 ±3.6 <0.001
EDG
(mm of Hg)
11.5± 7.2 8.6± 4.8 7.7 ±3.8 <0.001 10.9 ±7.2 8.6± 4.2 7.7 ±3.8 <0.001
RVSP
(mm of Hg)
39.7 ±22.4 31.2 ±13.6 27.2± 10.1 0.01 39.6 ±21.8 37.2± 21.8 35.3± 17.6 0.06
MVA (cm2) 1.2± 0.3 1.19± 0.3 1.17 ±0.3 0.86 1.2± 0.2 1.17 ±0.2 1.15± 0.2 0.56
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achieved MVA  1.5 sq cm and 10 patients developed at least
moderate to severe MR.6 patients were sent for emergent surgery
due to leaflet tear (n¼4)or severe commissural MR (n¼2)with low
output state. Of the patients sent for emergent surgery due to
severe MR, calcium nodule /irregular thickening of leaflet were
significant associations (p< 0.001).Higher grades of SVF correlated
with higher pre-PTMC pulmonary pressures and portended a
worse PTMC outcome. Using regression analysis and Pearson’s
rank relation, correlation coefficients for post-PTMC poorer out-
comes were significantly stronger for higher grades of SUBVALVE
DISEASE (r¼ 0.76 )and LEAFLET NODULAR CALCIFICATION(r¼0.72)
than the composite score (r¼0.67 )as also the other two variables
in the score(0.51 for M,0.47 for T).
Conclusion: Presence of calcium nodules on mitral leaflets,
irregular leaflet thickening of leaflets with thick/thin areas and
presence of severe subvalve disease were more predictive of
poorer outcomes of PTMC, than were mobility of valve or thick-
ening as per Wilkins’ scoring criteria. Among the above, worse
subvalve disease related to poorer gain of area immediately post
PTMC as well as higher residual gradients. Presence of calcium
nodules on leaflet as well as irregular leaflet thickening were
more predictive of give-way during balloon dilation and leaflet
tear ,leading to severe MR mandating immediate surgical in-
tervention.
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Background: Rheumatic mitral valve calcification (RMVC) is an
active inflammatory process. Balance of pro and anticalcific fac-
tors in the local milieu of the valve determine its susceptibility to
calcification.Vitamin D has been shown to have anti-inflamma-
tory and anticalcific effects .Till date no study has assessed its
levels in patients of RMVC compared to noncalcified rheumatic
valves.
Aim: To assess serum Vitamin D level in patients of RMVC
compared with non calcified valves and see correlation between
serum Vitamin D level and severity of mitral valve calcification
assessed by (TTE) transthoracic echocardiography ( wilkins cal-
cium score WCS).
Method: 30 patients each of rheumatic mitral valve with no
calcification (WCS 0, group 1) , mild calcification(WCS1 or 2, group
2) and severe calcification( WCS 3 or 4,group 3) have been studied (
study is ongoing and 55 patients will be enrolled in each group).
Serum calcium, phosphorus, alkaline phosphatase, parathor-
mone and 25 OH vitamin D (immunoassay Elecsys 2010 Roche,
Germany) were assessed.
Results: Mean age of three groups were similar (29.32±9.8 in group
1 , 31.68±7.23 in group 2, 32.75±9.83 in group 3 , p¼NS) . Serum Ca,
P, ALP, PTH, and ESR were also similar in all 3 groups (p¼NS).
Serum 25 OH vitamin D was siginificantly lower in group 3
(11.06±3.85 ng/ml , p <0.001 vs group 1) and group 2 (21.86±8.49 ng/
ml,p < 0.001 vs group 1) compared to group 1 (29.42±9.4 ng/ml ) . A
siginificant inverse correlation was identified between Vitamin D
level and severity of calcification (r ¼0.79, p<0.001). Vitamin D
level in non- calcified valves was near normal (normal value  30
ng/ml).
Conclusion: This is first study to show significant reduction in
vitamin D level in patients with RMVC . Thus a link may exist
between 25 OH vitamin D and calcification process in RMVC and
supplementation of oral Vitamin D to maintain normal level may
prevent or attenuate progressive valvular calcification.
Correlation of mitral valve area (MVA) with
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Background: It is observed that in MS dyspnea may not always
correlate with MVA. Study was carried out to access correlation of
MVA with severity of dyspnea.
Methods: Two hundred cases of pure MS in NYHA class I to IV
comprised material of this study. Detailed clinical evaluation
followed by ECG, XRAY and ECHO were done in all cases.
Results: Correlation of NYHA class to MVA is as follows-
NYHA class MVA<1sq.cm. MVA1-1.5sq.cm MVA1.5-2sq.cm. Tot
I (108) 2 8 98 108
II (56) 1 45 10 56
III (22) 2 16 4 22
IV (14) 10 2 2 14
Total 15 71 114 200
Disparity is observed betweenMVA andMYHA class of dyspnea.
Left atrial (LA) compliance , pulmonary vascular resistance (PVR),
stretchability of mitral valve ring play an important role. Thus
NYHA class I dyspneais observed in MVA less than 1 sq.cm. When
LA wall is compliant whereas with mild MS, NYHA class III or IV
dyspnea is observed if LA wall is non compliant.
Conclusions: It appears that dyspnea is not a reliable indicstor of
severity of MS.
Echocardiography as a basic criterion for
diagnosis of rheumatic fever and rheumatic heart
disease
A. Lalchandani, Mayuri Agarwal, S. Verma, T. Midha, M. Godara,
A. Garg, P. Singh, B.P. Priyadarshi, M. Naveen, Razi, P. Abhishek
PG Institute of Medicine, GSVM Medical College, Kanpur, India
Background: To study the role of 2D Echo Doppler in diagnosis of
Rheumatic fever and Rheumatic heart disease and to compare
echocardiography as a diagnostic criteria compared to Jones
Criteria of rheumatic fever (RF) and rheumatic heart disease
(RHD).
Methods: There were 32 patients included in study and were fol-
lowed over a period of one year from December 2011 to November
2012. Patients with any complaints related to criteria for diagnosis
of rheumatic fever and rheumatic heart disease whether present
or past were included and divided into two groups - Those with
positive echocardiographic evidence of carditis in patients diag-
nosed as ARF and RHD and those without echocardiographic ev-
idence of carditis in ARF and RHD. Those with clinical evidence of
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